CDK12-IN-E9 Size:Contact [email protected] for quotation 4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl]oxidanesulfonic acid

4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl]oxidanesulfonic acid

Pentagamavunon-1 (PGV-1)

and increases in the number of ChAT-immunoreactive cells in the medial septum in Ab-treated rats to the levels of vehicle-injected control rats

48 h) induce apoptosis in prostate cancer cells

Angiotensin II is produced from angiotensin I

CDK12-IN-E9 Size:Contact [email protected] for quotation 4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl]oxidanesulfonic acidCDK12 IN E9 is a potent and selective covalent CDK12 inhibitor and a non covalent CDK9 inhibitor, while avoiding ABC transporter mediated efflux. CDK12 IN E9 has weak binding ability to CDK7 CyclinH complex with an IC50> 1 M. Product information CAS Number: 2020052 55 3 Molecular Weight: 434. 53 Formula: C24H30N6O2 Chemical Name: N [3 ({3 ethyl 5 [(2S) 2 (2 hydroxyethyl)piperidin 1 yl]pyrazolo[1,5 a]pyrimidin 7 yl}amino)phenyl]prop 2 enamide Smiles: